Femtosecond LASER-Assisted Double Intraocular Lens Exchange in Nanophthalmic Eyes.

Introduction: Though patients with nanophthalmos frequently endure decreased quality of vision with contact lenses or spectacles, refractive surgery is generally an inadequate alternative due to the associated high refractive error. A refractive lens exchange (RLE) is an alternative option but is technically challenging, requiring accuracy in biometry measurements and procedures. Case Presentation: This case discusses a 27-year-old female with nanophthalmos (axial lengths 17.6 mm and 17.4 mm, right and left eyes, respectively) who underwent a femtosecond laser-assisted (FLA) RLE with simultaneous implantation of a monofocal and a Sulcoflex trifocal (Rayner, Britain) lens in each eye. Preoperative cycloplegic refraction was +11.50/-0.75 × 145 and +12.00/-1.00 × 35 in the RE and LE, respectively. Best-corrected visual acuity (BCVA) at distance and near in the RE and LE was 6/7.5 and J1, 6/8.5 and J2, respectively. Uncorrected visual acuity (UCVA) was >6/120 and >J14 for each eye. FLA RLE was performed in the RE, then in the LE 2 weeks later. In each eye, a monofocal (44.0 D, RE, and LE) and a Sulcoflex trifocal lens (both implants, Rayner, Britain) were implanted in one procedure. Distance and near UCVA measured 6 weeks post-op RE and 1-month post-op LE at 6/8.5 and J1 in the RE, 6/10 and J1 in the LE. The RE and LE refraction and BCVA were +0.50/-1.00 × 115, 6/7.5, and plano/-1.00 × 55, 6/8.5, respectively. The post-op outcomes were uneventful. Conclusion: A single procedure concurrently implanting a monofocal and Sulcoflex trifocal intraocular lens in nanophthalmic eyes resulted in an excellent UCVA. This procedure can be considered esthetic and reconstructive as it significantly improves patient appearance and function.

Repeated Femtosecond Laser-Assisted Astigmatic Keratotomies in Post-Keratoplasty Eyes.

Visual rehabilitation after a keratoplasty is often compromised due to high amounts of residual astigmatism. Femtosecond laser-assisted astigmatic keratotomy (FLAK) is gaining popularity in decreasing this astigmatism. Though one set of two incisions suffices in most cases, sometimes the treatment proves insufficient and additional treatment is required. This case series evaluates the outcomes in patients who underwent two consecutive FLAK sets to correct post-keratoplasty residual astigmatism. All repeated FLAK cases performed on post-keratoplasty eyes were reviewed in a high-volume clinic as a non-comparative retrospective case series. The data extracted include the procedure parameters, time between procedures, refraction including sphere, astigmatism, spherical equivalent (SE), and uncorrected and best-spectacle-corrected distance visual acuity (UDVA, BSDVA, respectively). Eleven eyes of eleven patients aged 25.5 ± 10 treated with more than one FLAK procedure were identified. The average follow-up time was 6 months after the first FLAK and 24 ± 10 months after the second. The second FLAK was performed six months after the first. The preoperative mean astigmatism was -9.59 ± 2.36 D. At the final follow-up, the mean astigmatism decreased to -5.38 ± 1.79 D (p = 0.001). Repeated FLAK procedures achieved a significant and stable reduction of astigmatism in post-keratoplasty eyes. This procedure shows safety and effectivity in these complex eyes and may prevent the need for a further keratoplasty.

LY6S, a New IFN-Inducible Human Member of the Ly6a Subfamily Expressed by Spleen Cells and Associated with Inflammation and Viral Resistance.

Syntenic genomic loci on human chromosome 8 and mouse chromosome 15 (mChr15) code for LY6/Ly6 (lymphocyte Ag 6) family proteins. The 23 murine Ly6 family genes include eight genes that are flanked by the murine Ly6e and Ly6l genes and form an Ly6 subgroup referred to in this article as the Ly6a subfamily gene cluster. Ly6a, also known as Stem Cell Ag-1 and T cell-activating protein, is a member of the Ly6a subfamily gene cluster. No LY6 genes have been annotated within the syntenic LY6E to LY6L human locus. We report in this article on LY6S, a solitary human LY6 gene that is syntenic with the murine Ly6a subfamily gene cluster, and with which it shares a common ancestry. LY6S codes for the IFN-inducible GPI-linked LY6S-iso1 protein that contains only 9 of the 10 consensus LY6 cysteine residues and is most highly expressed in a nonclassical spleen cell population. Its expression leads to distinct shifts in patterns of gene expression, particularly of genes coding for inflammatory and immune response proteins, and LY6S-iso1-expressing cells show increased resistance to viral infection. Our findings reveal the presence of a previously unannotated human IFN-stimulated gene, LY6S, which has a 1:8 ortholog relationship with the genes of the Ly6a subfamily gene cluster, is most highly expressed in spleen cells of a nonclassical cell lineage, and whose expression induces viral resistance and is associated with an inflammatory phenotype and with the activation of genes that regulate immune responses.

Acute cataract development in a 43-year-old woman after an ultrasound eyelid-tightening procedure.

PURPOSE: The purpose of this article is to describe a severe side effect presentation of a bilateral cataract after treatment with intense focused ultrasound (IFUS) and subsequent uneventful cataract surgery. OBSERVATIONS: A 43-year-old woman presented to the emergency room with decreased visual acuity several hours after undergoing an eyelid-tightening procedure using IFUS. The patient's vision was decreased (R>L), a result of an acute cataract, which had an unusual appearance and consistency. Several weeks later, visual acuity had decreased further in the right eye to 20/400 and the patient underwent uneventful laser-assisted cataract surgery with intraocular lens implantation, which resulted in full visual recovery. CONCLUSIONS AND IMPORTANCE: This case emphasizes the need for particular attention to possible side effects resulting from periocular IFUS, including severe ocular impact requiring surgical intervention.

Unilateral Refractive Lens Exchange with a Multifocal Intraocular Lens in Emmetropic Presbyopic Patients.

Purpose: To evaluate the visual outcome and patient satisfaction after a unilateral multifocal IOL implantation in the non-dominant eye of emmetropic patients with presbyopia. Methods: An interventional case series of consecutive patients who underwent unilateral phacoemulsification with femto-laser assisted cataract surgery (FLACS) and refractive lens exchange (RLE), followed by an implantation of a trifocal diffractive IOL (FineVision Micro F), was performed in the non-dominant eyes of emmetropic patients with presbyopia. After 6 months of follow-up, the main outcome measures were uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA), and uncorrected near visual acuity (UNVA). Secondary outcomes included spherical equivalent (SE), refraction, contrast sensitivity, patient questionnaire and presence of visual side effects. Results: A total of 26 eyes of 26 patients, with an average age of 53.8 ± 4.1 years, were included in this study. Preoperative mean UDVA was 0.13 ± 0.04 logMAR (Snellen 20/27), UIVA was 0.46 ± 0.12 logMAR (Snellen 20/58), and UNVA was 0.66 ± 0.17 logMAR (Snellen 20/91), in comparison to postoperative mean UDVA of 0.18 ± 0.32 logMAR (Snellen 20/30) (p = 0.32), UIVA of 0.17 ± 0.21 logMAR (Snellen 20/30) (p < 0.005), and UNVA of 0.02 ± 0.10 logMAR (Snellen 20/21) (p < 0.005). Monocular UNVA of 20/25 or better in the operated eye was achieved in 23 (88%) patients. Twenty-four (96%) patients said they would recommend this procedure to family and friends. There were no intraoperative complications and no IOL exchange was required. Conclusions: A unilateral RLE of the non-dominant eye with FLACS and a trifocal diffractive IOL (FineVision Micro F) implantation in emmetropic, presbyopic patients is provides satisfactory distance, intermediate, and near visual outcomes with no complications reported in this preliminary case series.

Outcome of "mushroom" pattern femtosecond laser-assisted keratoplasty versus conventional penetrating keratoplasty in patients with keratoconus.

PURPOSE: The aim of this study was to compare the outcomes of "mushroom" femtosecond laser-enabled keratoplasty (M-FLEK) with those of conventional penetrating keratoplasty (PKP) in eyes with keratoconus. The femtosecond laser-enabled "mushroom" pattern keratoplasty technique results in less postoperative astigmatism and higher endothelial cell counts compared with conventional PKP in patients with keratoconus. METHODS: This was a nonrandomized retrospective, single private center clinical study. Between March 2010 and April 2012, 26 eyes underwent M-FLEK and 33 eyes underwent conventional PKP. Data on preoperative and postoperative manifest refraction, uncorrected visual acuity and best-corrected visual acuity (BCVA), endothelial cell counts, vector analysis, and complications were retrieved and analyzed. RESULTS: At 12 months of follow-up, the mean logMAR BCVA was 0.31 ± 0.55 in the M-FLEK group and 0.32 ± 0.21 in the PKP group (P = 0.91). The mean spherical equivalent was similar between the groups. The mean manifest cylinder was significantly lower in the M-FLEK group (-2.84 ± 1.08 diopters) than in the PKP group (-3.93 ± 2.26 diopters; P = 0.03). There was a smaller mean endothelial cell loss in the M-FLEK group compared with the PKP group (32.1% vs 38.7%, respectively, P = 0.17) 1 year postoperatively. The complication rates were similar for both groups. CONCLUSIONS: M-FLEK appears to be a safe procedure that results in less astigmatism and a trend toward higher endothelial cell counts compared with conventional PKP, with similar postoperative BCVA.

Delayed epithelial healing following photorefractive keratectomy with mitomycin C treatment.

PURPOSE: To evaluate the epithelial healing following photorefractive keratectomy (PRK) with mitomycin C (MMC) 0.02%. METHODS: A total of 1520 eyes of 760 patients with myopia with spherical equivalent between -1.5 and -8.0 dioptres underwent PRK during 2004-2008. The epithelium was removed mechanically, and laser ablation was followed by topical application of MMC (0.02%) for 20 seconds. A therapeutic contact lens (TCL), kept in 4°C, was fitted and worn until complete epithelialization. Antibiotic, steroid and diclofenac drops were instilled during the healing phase. Steroid drops were used for 6-8 weeks and gradually reduced. The results were compared with a retrospective analysis of 500 myopic eyes which underwent PRK without MMC therapy during 2002-2004. RESULTS: In 30 MMC treated eyes (2%), epithelial healing was delayed with a stellate defect which healed after 12-14 days. Another fifteen eyes (1%) revealed loose midperipheral epithelium and complete epithelialization took 10-14 days after scraping. Two of these eyes developed recurrent erosion treated by scraping and TCL. Seven eyes (0.5%) revealed delayed healing with paracentral epithelial plaques which were scraped and complete healing took 12-14 days. No final haze was found in the MMC-treated eyes. In comparison, only 0.8% of the eyes which had undergone PRK without MMC revealed epithelial problems. Haze was found in 8% of these eyes. A statistically significant difference was found between the rate of epithelial problems of the two groups (p ≤ 0.002). CONCLUSIONS: MMC (0.02%) applied for 20 seconds post-PRK was found to delay epithelial wound healing up to 14 days in 3.5% of patients with myopia compared to 0.8% of PRK eyes without MMC application. Final haze was not found despite delayed epithelialization because of MMC treatment.

Wavefront-guided LASIK for myopia with the Technolas 217z: results at 3 years.

PURPOSE: To evaluate the clinical outcome of wavefront-guided LASIK in patients with low to high myopia. METHODS: The study included 316 eyes of 158 patients; 172 eyes with low to moderate myopia (< or = 6.00 diopters [D]) and 144 eyes with high myopia (> or = 6.25 D). Preoperative wavefront analysis was performed with the Hartmann-Shack aberrometer, and LASIK was done with the Technolas 217z excimer laser. Follow-up was 36 months. Safety, efficacy, predictability, stability, and complications were compared between groups. RESULTS: Mean preoperative spherical equivalent refraction (SE) was -6.50 +/- 7.72 D (range: -1.50 to -16.00 D) in the entire study group, -4.91 +/- 1.38 D in the low to moderate myopia group, and -9.41 +/- 2.51 D in the high myopia group. At 36 months, 222 (70%) eyes showed no change in best spectacle-corrected visual acuity and 67 (21%) eyes gained > or = 1 line. In the low to moderate myopia group, SE of +/- 0.50 D was achieved by 85% of eyes and +/- 1.00 D by 97%, and 65% and 80%, respectively, in the high myopia group. Undercorrection > 0.50 D was observed in 25% (36 eyes) of the high myopia group and 5% (8 eyes) of the low to moderate myopia group. All eyes showed significant reduction in spherical aberration (Z4,0) at 12 months postoperatively with no complications except diffuse lamellar keratitis in 2 eyes (1 eye in each group). CONCLUSIONS: Wavefront-guided LASIK is an efficient refractive surgery technique for patients with low to moderate myopia. Higher degrees of myopia may be subject to under- and overcorrection.

Wavefront-supported photorefractive keratectomy with the Bausch & Lomb Zyoptix in patients with myopic astigmatism and suspected keratoconus.

PURPOSE: To evaluate the safety, efficacy, and visual outcome of wavefront-supported photorefractive keratectomy (PRK) for the correction of myopia and myopic astigmatism in patients with suspected keratoconus. METHODS: Forty eyes of 20 patients with myopia -4.0 to -8.0 diopters (D) (mean: -6.25 +/- 1.04 D), cylinder -1.0 to -2.50 D (mean: -1.61 +/- 0.71 D), and corneal thickness 440 to 488 microm were treated with wavefront-supported PRK. Corneal topography evaluation revealed a significantly irregular cylinder (inferior-superior difference > 1.5 D) with possible mild or forme fruste keratoconus. Aberrometry was performed with the Hartmann-Shack aberrometer, and corneal data were evaluated with the Orbscan system. Eyes were treated with the Technolas 217z Bausch & Lomb excimer laser and followed for a minimum of 40 months. RESULTS: Following surgery, mean spherical equivalent refraction was +0.33 +/- 0.8 D. It was within +/- 0.5 D of the intended refraction in 95% of eyes and within +/- 1.0 D in 100% of eyes. Mean uncorrected visual acuity improved from 20/400 preoperatively to 20/25 postoperatively. Mean best spectacle-corrected visual acuity (BSCVA) remained unchanged (20/20) or improved to 20/20 in 92.5% of eyes and to 20/25 in 7.5% of eyes. Individually, BSCVA did not change in 28 (70%) eyes and increased by > or = 2 Snellen lines in 9 (22.5%) eyes; 3 (7.5%) eyes lost 1 Snellen line because of corneal haze. Laser treatment induced a significant flattening of the preoperative inferior corneal steepness in all eyes. Wavefront analysis demonstrated a significant decrease in high order aberrations (total root-mean-square and coma). CONCLUSIONS: Wavefront-supported PRK appears to be effective for the treatment of myopia and astigmatism in patients with suspected keratoconus and thin, irregular corneas. Longer follow-up is needed to prove the safety of the procedure in this patient population.

[Evaluation of efficacy, safety and stability of lasik-zyoptix as compared to lasik-planoscan in myopia patients with or without astigmatism].

AIM: To compare the efficacy, safety and stability of laser in-situ keratomileusis (LASIK) Zyoptix and PlanoScan (PS) systems for the surgical correction of myopia with and without astigmatism. METHODS: In this retrospective study we analyzed the results of 198 eyes of 99 patients (randomly chosen) who underwent LASIK Zyoptix treatment and 198 eyes of 99 patients (randomly chosen) who underwent LASIK PlanoScan standard ablation treatment. Patients were followed for a period of 12 months after treatment. All surgeries were performed with the Bausch & Lomb Technolas 217z. Data on uncorrected (UCVA) and best spectacle-corrected (BSCVA) visual acuity, efficacy, predictability, stability and safety were analyzed. RESULTS: Mean preoperative spherical error in the Zyoptix group was -7.16 D (range= 0 to -16.50, SD = 3.21) and in the PS group -5.31 D (range= 0 to -16.50, SD=3.13). Mean preoperative cylinder was -1.30 D (range= -0.25 to 5.00, SD=0.99) and -1.17 D (range= -1 to -4.00, SD=0.85) respectively. Mean spherical deviation from expected at 1 year in the Zyoptix group was -0.13 D (range= -1.75 to 2, SD=0.73) and in the PS group -0.16 D (range= -4.50 to 2, SD = 0.75). Mean cylinder at 1 year was -0.69 D (range= -0.50 to 0.75, SD= -0.13) and -0.69 D (range = 0 to -2.25, SD = 0.46) respectively. At 1 year, the UCVA in the Zyoptix group was 6/12 or better, 6/7.5 or better and 6/6 or better in 87%, 60% and 27% respectively, and in the PS group 92%, 64% and 39% respectively. CONCLUSIONS: Both treatments can safely and effectively treat myopia and astigmatism with stable results up to one year. Zyoptix was found to show better outcomes in terms of safety and efficacy.

Late bilateral keratectasia after LASIK in a low myopic patient.

PURPOSE: To report a rare case of late bilateral ectasia developing after LASIK for low myopia without preoperative risk factors. METHODS: A 21-year-old man underwent bilateral uneventful LASIK for low myopia of -2.75 diopters in both eyes. Preoperative corneal pachymetry was 531 microm in the right eye and 526 microm in the left eye. The total ablation depth was 46.8 microm in the right eye and 42.2 microm in the left eye. Preoperative corneal topography was normal and did not reveal forme fruste keratoconus. RESULTS: Twenty-four months postoperatively, the patient developed bilateral inferior keratectasia of +0.50 -3.00 x 72 degrees in the right eye and +1.00 -2.75 x 99 degrees in the left eye. CONCLUSIONS: Late keratectasia may follow LASIK for low myopia despite a thorough preoperative work-up.

Clinical outcome of wavefront-guided laser in situ keratomileusis in eyes with moderate to high myopia with thin corneas.

PURPOSE: To evaluate the clinical outcome of wavefront-guided laser in situ keratomileusis (LASIK) for the treatment of moderate to high myopia associated with a thin cornea. SETTING: Enaim Laser Medical Center, Tel Aviv, Israel. METHODS: This retrospective study included 98 eyes of 49 patients with moderate to high myopia (-5.20 to -10.35 diopters [D]) and thin corneas (456 to 498 mum) treated with wavefront-guided LASIK (Zyoptix, Bausch & Lomb) and followed for 36 months. Preoperative wavefront analysis was performed with a Hartmann-Shack aberrometer, and treatment was performed with the Technolas 217 z excimer laser system (Bausch & Lomb). Final refraction data, uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA), optic zone size, ablation depth, optical aberrations, and night glare complaints were evaluated. RESULTS: Mean patient age was 28 years +/- 7 (SD), and mean preoperative spherical equivalent refraction was -7.06 D (range -5.20 to -10.35 D). Final UCVA ranged between 6/6 and 6/30. The safety index of the technique was 1.03, and the efficacy index was 0.67. Undercorrection of more than 0.50 D was observed in 41.3% of the high-myopic eyes (-7.00 to -10.35 D, n = 58) compared with 10% in the moderately myopic eyes (-5.00 to -6.75 D, n = 40). A significant reduction in spherical aberration (Z(4)0) was found 12 months postoperatively in all eyes. Night glare was documented in 4 eyes (4%) in the high myopia group. There were no cases of corneal ectasia. CONCLUSION: Zyoptix was safe in eyes with moderate to high myopia with relatively thin corneas (<498 microm). For myopia between -7.00 D and -10.35 D, a small optical zone (4.3 to 5.6 mm) may be applied as night glare was relatively rare, but significant undercorrection should be expected.

Peripheral sterile corneal infiltrates after refractive surgery.

PURPOSE: To report 5 eyes of peripheral sterile corneal infiltrates after refractive surgery. SETTING: Department of Ophthalmology, Soroka University Medical Center, Beer-Sheva, Israel, and Enaim Ophthalmological Center, Jerusalem, Israel. METHODS: Three patients had bilateral refractive procedures for correcting myopia. The procedures included laser epithelial keratectomy in 2 eyes, laser in situ keratomileusis (LASIK) in 2 eyes using a keratome, and LASIK in 1 eye using femtosecond laser. RESULTS: All the patients complained of ocular pain between 1 and 3 days after the procedure. A ring stromal infiltrate peripheral to the flap edge with intact epithelium and an intervening clear zone between the peripheral corneal infiltrates and the limbus was observed in 5 eyes without anterior chamber reaction. All cases improved after several days of topical steroid and antibiotic treatment and systemic steroid. Final visual acuity was 20/25 or better in all cases. CONCLUSIONS: The exact mechanism of this complication is still unknown, which can be confused with infectious keratitis. It is important to maintain a high degree of suspicion for infectious keratitis because the management is very different. The potential outcome can be much worse if the keratitis is due to an infectious etiology which can appear after all types of refractive laser procedures.

Anterior chamber gas bubbles after corneal flap creation with a femtosecond laser.

A 48-year-old woman had bilateral wavefront-guided laser in situ keratomileusis for myopia with IntraLase corneal flap creation. In the right eye the cavitation bubbles were observed not only in the interface between the flap and the corneal bed but also in the anterior chamber disappearing after 30 minutes. After the procedure, uncorrected visual acuity is 20/25 in both eyes; and specular microscopy shows normal hexagonal cells and density. Although no postoperative complications were observed in our case, further follow-up is needed to examine the long-term effect of this phenomenon of IntraLase.

Artisan phakic intraocular lens for correcting high myopia.

OBJECTIVES: To evaluate the safety indexes and efficacy of Artisan phakic intraocular lens (IOL) for the correction of high myopia. METHODS: Retrospective interventional case series reports. Thirty-one eyes (22 patients) with myopia from -5.25 to -19.00 diopters underwent implantation of an Artisan phakic IOL. Follow-up examinations were performed at 1 day, 1 week, 1 month, and 3 months. The following parameters were recorded: manifest refraction, slit-lamp examination, applanation tonometry, uncorrected visual acuity (UCVA), best spectacle-corrected visual acuity (BSCVA), complications or adverse reactions. The primary variable was the refractive outcome at 3 months. Secondary variables were change in BSCVA, and efficacy and safety indexes. RESULTS: At 3 months, mean spherical equivalent was -0.50 +/- 0.36 diopters (range, -1.25 - plano). In 29 eyes (93.5%) UCVA was 6/12 or better; the other three eyes had UCVA of 6/15. The difference between preoperative and 1 week postoperative BSCVA was not statistically significant (p = 0.25). Comparison of BSCVA at 1 week and at 1 month was statistically significant (p = 0.05); this difference was even more significant at 3 months (p = 0.01). The BSCVA remained the same or improved for all the eyes. BSCVA for 20 eyes (64.5%) had improved one or more lines in visual acuity. Mean endothelial cell loss at 3 months was 3.96%. CONCLUSION: The Artisan lens is a safe, predictable, and efficacious method to correct high myopia. Postoperative gain in BSCVA was achieved for the majority of eyes. Future study to assess safety indexes and risk of complications is required with long-term follow-up.